Brain TSPO-PET predicts later disease progression independent of relapses in multiple sclerosis

…, M Matilainen, J Tuisku, E Polvinen, A Vuorimaa… - Brain, 2020 - academic.oup.com
Overactivation of microglia is associated with most neurodegenerative diseases. In this
study we examined whether PET-measurable innate immune cell activation predicts multiple …

Natalizumab treatment reduces microglial activation in the white matter of the MS brain

…, J Tuisku, M Matilainen, A Vuorimaa… - Neurology …, 2019 - AAN Enterprises
Objective To evaluate whether natalizumab treatment reduces microglial activation in MS.
Methods We measured microglial activation using the 18-kDa translocator protein (TSPO)-…

High serum neurofilament associates with diffuse white matter damage in MS

…, M Sucksdorff, S Laaksonen, A Vuorimaa… - Neurology …, 2020 - AAN Enterprises
Objective To evaluate to which extent serum neurofilament light chain (NfL) increase is
related to diffusion tensor imaging–MRI measurable diffuse normal-appearing white matter (…

Insights into disseminated MS brain pathology with multimodal diffusion tensor and PET imaging

…, J Tuisku, M Matilainen, A Vuorimaa… - Neurology …, 2020 - AAN Enterprises
Objective To evaluate in vivo the co-occurrence of microglial activation and microstructural
white matter (WM) damage in the MS brain and to examine their association with clinical …

[HTML][HTML] In Vivo PET Imaging of Adenosine 2A Receptors in Neuroinflammatory and Neurodegenerative Disease

A Vuorimaa, E Rissanen, L Airas - Contrast Media & Molecular …, 2017 - hindawi.com
Adenosine receptors are G-protein coupled P1 purinergic receptors that are broadly
expressed in the peripheral immune system, vasculature, and the central nervous system (CNS). …

Positron emission tomography imaging in evaluation of MS pathology in vivo

H Högel, E Rissanen, A Vuorimaa… - Multiple Sclerosis …, 2018 - journals.sagepub.com
Positron emission tomography (PET) gives an opportunity to quantitate the expression of
specific molecular targets in vivo and longitudinally in brain and thus enhances our possibilities …

Longitudinal stability of progression‐related microglial activity during teriflunomide treatment in patients with multiple sclerosis

…, M Sucksdorff, A Vuorimaa… - European Journal of …, 2023 - Wiley Online Library
Background and purpose The aim was to study brain innate immune cell activation in
teriflunomide‐treated patients with relapsing–remitting multiple sclerosis. Methods Imaging with 18…

Association of serum neurofilament light with microglial activation in multiple sclerosis

M Saraste, M Matilainen, A Vuorimaa… - Journal of Neurology …, 2023 - jnnp.bmj.com
Background Translocator protein (TSPO)-PET and neurofilament light (NfL) both report on
brain pathology, but their potential association has not yet been studied in multiple sclerosis (…

[PDF][PDF] Longitudinal stability of progression-related microglial activity during teriflunomide treatment in patients with multiple sclerosis

A Vuorimaa, J Rajander, S Wahlroos, P Hariri, L Airas - 2023 - research.abo.fi
Background and purpose: The aim was to study brain innate immune cell activation in
teriflunomide-treated patients with relapsing–remitting multiple sclerosis. Methods: Imaging with 18…

Insights into smouldering MS brain pathology with multimodal diffusion tensor and PET imaging

S Bezukladova, J Tuisku, M Matilainen, A Vuorimaa… - medRxiv, 2020 - medrxiv.org
Objective To evaluate in vivo the co-occurrence of microglial activation and microstructural
white matter damage in multiple sclerosis (MS) brain, and to examine their association with …